Pulse Biosciences, Inc.
PLSE
Clasificación en acciones
#4283
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric... Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Precio por acción
$51.39
Última sincronización: 2026-10-21
Capitalización bursátil
$3.67B
Cambio (1 día)
1.09%
Cambio (1 año)
197.94%
País
US
Comercio Pulse Biosciences, Inc. (PLSE)
Categoría
Healthcare
Historial de rendimiento por dividendo de Pulse Biosciences, Inc. (PLSE)
Rendimiento por dividendo (TTM) de Pulse Biosciences, Inc. (símbolo bursátil: PLSE) al 2026: 0
Rendimiento promedio por dividendo de los últimos 5 años: 0.00%
Rendimiento promedio por dividendo de los últimos 5 años: 0.00%
Historial de rendimiento por dividendo de Pulse Biosciences, Inc. (PLSE) desde 2026 hasta 2026
Rendimiento por dividendo al final de cada año (TTM)
| Año | Rendimiento por dividendo | Cambiar |
|---|---|---|
| Not enough data for the provided dates. | ||
Rendimientos por dividendo (TTM) de empresas similares o competidoras
| Empresa | Rendimiento por dividendo | País |
|---|---|---|
| 0.00% |
US
|
|
| 2.70% |
FR
|
|
| 0.00% |
JP
|
|
| 2.10% |
US
|
|
| 0.00% |
CH
|
